JT
IMCR icon

Jupiter Topco’s Immunocore IMCR Stock Holding History

Jupiter Topco’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Buy
+709,022
New +$21M 0.01% 626

Other funds holding IMCR

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jupiter Topco's IMCR Position: Q2 2026 in Review

Jupiter Topco opened a new position in Immunocore (IMCR) in Q2 2026: 709,022 shares worth $22.5M. The stake represents 0.01% of the portfolio and ranks #626 among its holdings.

119 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Jupiter Topco held 709,022 shares of Immunocore worth $22.5M as of Q2 2026.
  • Immunocore was a new Jupiter Topco position in Q2 2026.
  • Immunocore made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #626 holding.
  • 119 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.